(Q71975966)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

"Glitazones", a prospect for non-insulin-dependent diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

J Petrie

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

M Small

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J Connell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

9045

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

70-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis of NIDDM. A balanced overview

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2922002-7

7 January 2021

Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2922002-7

7 January 2021

New Pharmacological Approaches to Insulin and Lipid Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2922002-7

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2922002-7

7 January 2021

Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2922002-7

7 January 2021

Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2922002-7

7 January 2021

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2922002-7

7 January 2021

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2922002-7

7 January 2021

10.1016/S0140-6736(97)22002-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8996411%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference